phrykt

Longevity Health Holdings, Inc. (XAGE): who owns it and who trades it

As of Oct 30, 2026, XAGE insiders reported 1 purchase worth $200K in the last 12 months. The largest buyer was J. Ram Ajjarapu (CEO), with $200K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, XAGE insiders reported $200K of open-market purchases and $0 of sales.

Purchases, 12 months
$200K
1 trades, 1 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Mar 16, 2026
Filed Apr 8, 2026

Purchases and sales by month

$200K$200KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Mar 16, 2026J. Ram AjjarapuCEOPurchase689,656$0.29$200KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
J. Ram AjjarapuChief Executive Officer, Director, 10% owner$200K–Mar 16, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

XAGE short interest

Low short interest. 0.1% of XAGE shares are sold short: about 1 share in 837. Over the last 12 reports the number of shares short barely changed.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 2,958 XAGE shares were sold short, 0.1% of the shares outstanding, unchanged from the report before. At the average daily volume of 2,319 shares, buying them all back would take about 1.3 trading days (days to cover).

Shares short, % of all shares

0.12%May 15Oct 300.13%

Days to cover

1.3May 15Oct 302.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262,9580.12%No change2,3191.3
Oct 15, 20262,9580.12%No change7,0351.0
Sep 30, 20262,9580.12%No change3,1831.0
Sep 15, 20262,9580.12%-6%5,3151.0
Aug 31, 20263,1540.13%+7%1,6611.9
Aug 14, 20262,9580.12%-6%1,8421.6
Jul 31, 20263,1450.13%+7%1,3642.3
Jul 15, 20262,9490.12%No change1,9411.5
Jun 30, 20262,9490.12%-6%2,0841.4
Jun 15, 20263,1450.13%No change2,1961.4
May 29, 20263,1450.13%+6%9,5061.0
May 15, 20262,9580.12%-0%1,1612.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Longevity Health Holdings company events

Longevity Health Holdings filed 7 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Sep 8, 2026.

  1. Sep 8, 2026AnnouncementThe Company issued a press release announcing that the Company entered into a new securities purchase agreement with Puritan Partners LLC. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. Filing
  2. Sep 4, 2026AgreementLongevity Health Holdings, Inc. entered into a Securities Purchase Agreement with Puritan Partners LLC, an existing investor in the Company, pursuant to which the Company issued and sold to Puritan a 10% Senior Secured Convertible Note due February 29, 2028, in the original principal amount of… Filing
  3. Aug 17, 2026AnnouncementThe Company issued a press release announcing the settlement of litigation with Puritan Partners LLC. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. Filing
  4. Aug 14, 2026LeadershipScott Frisch notified Longevity Health Holdings, Inc. of his resignation from the Board of Directors of the Company, effective as of the close of business on August 11, 2026. Filing
  5. Jun 4, 2026LeadershipKathryn Gregory notified Longevity Health Holdings, Inc. of her resignation from the Board of Directors of the Company, effective as of the close of business on June 1, 2026. Filing
  6. Mar 17, 2026LeadershipResignation of Rajiv S. Shukla Effective as of the Closing Date, Rajiv S. Shukla stepped down from his positions as the Chief Executive Officer of the Company, a Class III director of the Company and the Chairman of the Board. Filing
  7. Dec 12, 2025AgreementEnded an important agreement. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Longevity Health Holdings financials

Questions about Longevity Health Holdings, Inc. (XAGE) stock

Are XAGE insiders buying or selling?

In the last 12 months, XAGE insiders reported 1 open-market purchase worth $200K and no sales. The latest trade was on Mar 16, 2026. See every trade.

What is the short interest in XAGE?

As of Oct 30, 2026, 2,958 XAGE shares were sold short, 0.1% of the shares outstanding, unchanged from the report before. At the average daily volume of 2,319 shares, buying them all back would take about 1.3 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.